{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:07:50Z","timestamp":1794542870682,"version":"4.9.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Ministry of Science, Technology and Productive Innovation, Argentina | Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2014-3687"],"award-info":[{"award-number":["PICT 2014-3687"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Ministry of Science, Technology and Productive Innovation, Argentina | Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2017-0494"],"award-info":[{"award-number":["PICT 2017-0494"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Ministry of Science, Technology and Productive Innovation, Argentina | Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2012-0164"],"award-info":[{"award-number":["PICT 2012-0164"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Ministry of Science, Technology and Productive Innovation, Argentina | Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT 2015-0122"],"award-info":[{"award-number":["PICT 2015-0122"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bunge & Born Foundation, Sales Foundation, Ren\u00e9 Baron Foundation and Richard Lounsbery Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Non-melanoma skin cancer (NMSC) has risen dramatically as a result of chronic exposure to sunlight ultraviolet (UV) radiation, climatic changes and clinical conditions associated with immunosuppression. In spite of considerable progress, our understanding of the mechanisms that control NMSC development and their associated molecular and immunological landscapes is still limited. Here we demonstrated a critical role for galectin-7 (Gal-7), a \u03b2-galactoside-binding protein preferentially expressed in skin tissue, during NMSC development. Transgenic mice (\n                    <jats:italic>Tg46)<\/jats:italic>\n                    overexpressing Gal-7 in keratinocytes showed higher number of papillomas compared to WT mice or mice lacking Gal-7 (\n                    <jats:italic>Lgals7<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    ) when subjected to a skin carcinogenesis protocol, in which tumor initiator 7,12-dimethylbenz[a]anthracene (DMBA) and tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate (TPA) were sequentially administered. RNAseq analysis of\n                    <jats:italic>Tg46<\/jats:italic>\n                    tumor lesions revealed a unique profile compatible with cells of the myelomonocytic lineage infiltrating these tumors, an effect that was substantiated by a higher number of CD11b\n                    <jats:sup>+<\/jats:sup>\n                    Gr1\n                    <jats:sup>+<\/jats:sup>\n                    cells in tumor-draining lymph nodes. Heightened c-Met activation and Cxcl-1 expression in\n                    <jats:italic>Tg46<\/jats:italic>\n                    lesions suggested a contribution of this pathway to the recruitment of these cells. Remarkably, Gal-7 bound to the surface of CD11b\n                    <jats:sup>+<\/jats:sup>\n                    Ly6C\n                    <jats:sup>hi<\/jats:sup>\n                    Ly6G\n                    <jats:sup>lo<\/jats:sup>\n                    monocytic myeloid cells and enhanced their immunosuppressive activity, as evidenced by increased IL-10 and TGF-\u03b2\n                    <jats:sub>1<\/jats:sub>\n                    secretion, and higher T-cell inhibitory activity. In vivo, carcinogen-treated\n                    <jats:italic>Lgals7<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>\u2212\/\u2212<\/jats:italic>\n                    <\/jats:sup>\n                    animals adoptively transferred with Gal-7-conditioned monocytic myeloid cells developed higher number of papillomas, whereas depletion of these cells in\n                    <jats:italic>Tg46<\/jats:italic>\n                    -treated mice led to reduction in the number of tumors. Finally, human NMSC biopsies showed increased\n                    <jats:italic>LGALS7<\/jats:italic>\n                    mRNA and Gal-7 protein expression and displayed transcriptional profiles associated with myeloid programs, accompanied by elevated CXCL1 expression and c-Met activation. Thus, Gal-7 emerges as a critical mediator of skin carcinogenesis and a potential therapeutic target in human NMSC.\n                  <\/jats:p>","DOI":"10.1038\/s41418-022-01108-7","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T11:17:09Z","timestamp":1674559029000},"page":"906-921","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Galectin-7 reprograms skin carcinogenesis by fostering innate immune evasive programs"],"prefix":"10.1038","volume":"30","author":[{"given":"Nicol\u00e1s A.","family":"Pinto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9206-2369","authenticated-orcid":false,"given":"Mart\u00edn C.","family":"Abba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Laporte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"P\u00e9rez S\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada G.","family":"Blidner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s I.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M.","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina G.","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila A.","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florencia","family":"Veigas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n J.","family":"Garc\u00eda Rivello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane H.","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene Juel","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego O.","family":"Croci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Sundblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0947-8735","authenticated-orcid":false,"given":"Gabriel A.","family":"Rabinovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1888-1227","authenticated-orcid":false,"given":"Juan P.","family":"Cerliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,24]]},"reference":[{"key":"1108_CR1","unstructured":"Cancer incidence and mortality worldwide. Lyon, France: Global Cancer Observatory, International Agency for Research on Cancer. 2020. http:\/\/gco.iarc.fr."},{"key":"1108_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0140-6736(09)61196-X","volume":"375","author":"V Madan","year":"2010","unstructured":"Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet. 2010;375:673\u201385.","journal-title":"Lancet."},{"key":"1108_CR3","doi-asserted-by":"publisher","first-page":"5394","DOI":"10.3390\/ijms21155394","volume":"21","author":"M Cives","year":"2020","unstructured":"Cives M, Mannavola F, Lospalluti L, Sergi MC, Cazzato G, Filoni E, et al. Non-melanoma skin cancers, biological and clinical features. Int J Mol Sci. 2020;21:5394.","journal-title":"Int J Mol Sci"},{"key":"1108_CR4","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/bjd.18552","volume":"182","author":"R Dummer","year":"2020","unstructured":"Dummer R, Guminksi A, Gutzmer R, Lear JT, Lewis KD, Chang ALS, et al. Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma, 42-month analysis of the phase II randomized, double-blind BOLT study. Br J Dermatol. 2020;182:1369\u201378.","journal-title":"Br J Dermatol."},{"key":"1108_CR5","doi-asserted-by":"publisher","first-page":"9300","DOI":"10.3390\/ijms21239300","volume":"21","author":"A Wessely","year":"2020","unstructured":"Wessely A, Steeb T, Leiter U, Garbe C, Berking C, Heppt MV. Immune checkpoint blockade in advanced cutaneous squamous cell carcinoma: what do we currently know in 2020? Int J Mol Sci. 2020;21:9300.","journal-title":"Int J Mol Sci."},{"key":"1108_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nri3646","volume":"14","author":"M Pasparakis","year":"2014","unstructured":"Pasparakis M, Haase I, Nestle FO. Mechanisms regulating skin immunity and inflammation. Nat Rev Immunol. 2014;14:289\u2013301.","journal-title":"Nat Rev Immunol."},{"key":"1108_CR7","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1042\/BCJ20160471","volume":"473","author":"RP Feehan","year":"2016","unstructured":"Feehan RP, Shantz LM. Molecular signaling cascades involved in nonmelanoma skin carcinogenesis. Biochem J. 2016;473:2973\u201394.","journal-title":"Biochem J"},{"key":"1108_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.20182041","volume":"217","author":"MR Girotti","year":"2020","unstructured":"Girotti MR, Salatino M, Dalotto-Moreno T, Rabinovich GA. Sweetening the hallmarks of cancer, Galectins as multifunctional mediators of tumor progression. J Exp Med. 2020;217:1\u201314.","journal-title":"J Exp Med"},{"key":"1108_CR9","doi-asserted-by":"publisher","first-page":"6086","DOI":"10.1158\/1078-0432.CCR-18-3870","volume":"26","author":"P Navarro","year":"2020","unstructured":"Navarro P, Mart\u00ednez-Bosch N, Blidner AG, Rabinovich GA. Impact of galectins in resistance to anticancer therapies. Clin. Cancer Res. 2020;26:6086\u2013101.","journal-title":"Clin. Cancer Res"},{"key":"1108_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0304-4165(02)00313-6","volume":"1572","author":"FT Liu","year":"2002","unstructured":"Liu FT, Patterson RJ, Wang JL. Intracellular functions of galectins. Biochim Biophys Acta. 2002;1572:263\u201373.","journal-title":"Biochim Biophys Acta."},{"key":"1108_CR11","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/cdd.2013.50","volume":"20","author":"RG Lichtenstein","year":"2013","unstructured":"Lichtenstein RG, Rabinovich GA. Glycobiology of cell death: when glycans and lectins govern cell fate. Cell Death Differ. 2013;20:976\u201386.","journal-title":"Cell Death Differ"},{"key":"1108_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1046\/j.1432-0436.1998.6330159.x","volume":"63","author":"T Magnaldo","year":"1998","unstructured":"Magnaldo T, Fowlis D, Darmon M. Galectin-7, a marker of all types of stratified epithelia. Differentiation. 1998;63:159\u201368.","journal-title":"Differentiation."},{"key":"1108_CR13","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s00018-005-5458-8","volume":"63","author":"S Saussez","year":"2006","unstructured":"Saussez S, Kiss R. Galectin-7. Cell Mol Life Sci. 2006;63:686\u201397.","journal-title":"Cell Mol Life Sci"},{"key":"1108_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/JID.2015.366","volume":"136","author":"HL Chen","year":"2016","unstructured":"Chen HL, Chiang PC, Lo CH, Lo YH, Hsu DK, Chen HY, et al. Galectin-7 regulates keratinocyte proliferation and differentiation through JNK-miR-203-p63 signaling. J Investig Dermatol. 2016;136:182\u201391.","journal-title":"J Investig Dermatol."},{"key":"1108_CR15","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/38525","volume":"389","author":"K Polyak","year":"1997","unstructured":"Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature. 1997;389:300\u20135.","journal-title":"Nature."},{"key":"1108_CR16","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1091\/mbc.e08-02-0166","volume":"19","author":"G Gendronneau","year":"2008","unstructured":"Gendronneau G, Sidhu SS, Delacour D, Dang T, Calonne C, Houzelstein D, et al. Galectin-7 in the control of epidermal homeostasis after injury. Mol Biol Cell. 2008;19:5541\u20139.","journal-title":"Mol Biol Cell."},{"key":"1108_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1001\/archopht.121.1.82","volume":"121","author":"Z Cao","year":"2003","unstructured":"Cao Z, Said N, Wu K, Kuwabara I, Liu F, Panjwani N. Galectin-7 as a potential mediator of corneal epithelial cell migration. Arch Ophthalmol. 2003;121:82\u201386.","journal-title":"Arch Ophthalmol."},{"key":"1108_CR18","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/cea.13672","volume":"50","author":"T Umayahara","year":"2020","unstructured":"Umayahara T, Shimauchi T, Iwasaki M, Sakabe JI, Aoshima M, Nakazawa S, et al. Protective role of Galectin-7 for skin barrier impairment in atopic dermatitis. Clin Exp Allergy 2020;50:922\u201331.","journal-title":"Clin Exp Allergy"},{"key":"1108_CR19","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1111\/1346-8138.16048","volume":"48","author":"N Pinto","year":"2021","unstructured":"Pinto N, Rabinovich GA, Sundblad V, Cerliani JP. Enhanced galectin-7 expression favors wound healing. J Dermatol. 2021;48:1616\u20138.","journal-title":"J Dermatol"},{"key":"1108_CR20","doi-asserted-by":"publisher","first-page":"e130740","DOI":"10.1172\/JCI130740","volume":"131","author":"HL Chen","year":"2021","unstructured":"Chen HL, Lo CH, Huang CC, Lu MP, Hu PY, Chen CS, et al. Galectin-7 downregulation in lesional keratinocytes contributes to enhanced IL-17A signaling and skin pathology in psoriasis. J Clin Invest. 2021;131:e130740.","journal-title":"J Clin Invest"},{"key":"1108_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms18122760","volume":"18","author":"T Advedissian","year":"2017","unstructured":"Advedissian T, Deshayes F, Viguier M. Galectin-7 in epithelial homeostasis and carcinomas. Int J Mol Sci. 2017;18:1\u201331.","journal-title":"Int J Mol Sci."},{"key":"1108_CR22","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.3390\/biom11111720","volume":"11","author":"NV Sewgobind","year":"2021","unstructured":"Sewgobind NV, Albers S, Pieters RJ. Functions and inhibition of galectin-7, an emerging target in cellular pathophysiology. Biomolecules. 2021;11:1720.","journal-title":"Biomolecules."},{"key":"1108_CR23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.bbrc.2009.07.015","volume":"387","author":"M Demers","year":"2009","unstructured":"Demers M, Couillard J, Giglia-Mari G, Magnaldo T, St-Pierre Y. Increased galectin-7 gene expression in lymphoma cells is under the control of DNA methylation. Biochem Biophys Res Commun. 2009;387:425\u20139.","journal-title":"Biochem Biophys Res Commun."},{"key":"1108_CR24","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.2353\/ajpath.2010.090876","volume":"176","author":"M Demers","year":"2010","unstructured":"Demers M, Rose AA, Grosset AA, Biron-Pain K, Gaboury L, Siegel PM, et al. Overexpression of galectin-7, a myoepithelial cell marker, enhances spontaneous metastasis of breast cancer cells. Am J Pathol. 2010;176:3023\u201331.","journal-title":"Am J Pathol"},{"key":"1108_CR25","first-page":"1","volume":"10","author":"X Zhu","year":"2021","unstructured":"Zhu X, Ding M, Yu ML, Feng MX, Tan LJ, Zhao FK. Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis. BMC Cancer. 2021;10:1\u201312.","journal-title":"BMC Cancer"},{"key":"1108_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0131307","volume":"10","author":"M Labrie","year":"2015","unstructured":"Labrie M, Vladoiu M, Leclerc BG, Grosset AA, Gaboury L, Stagg J, et al. A mutation in the carbohydrate recognition domain drives a phenotypic switch in the role of galectin-7 in prostate cancer. PLoS One. 2015;10:1\u201319.","journal-title":"PLoS One"},{"key":"1108_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0166731","volume":"11","author":"AA Grosset","year":"2016","unstructured":"Grosset AA, Poirier F, Gaboury L, St-Pierre Y. Galectin-7 expression potentiates HER-2-positive phenotype in breast cancer. PLoS One. 2016;11:1\u201312.","journal-title":"PLoS One"},{"key":"1108_CR28","doi-asserted-by":"publisher","first-page":"41986","DOI":"10.18632\/oncotarget.9749","volume":"7","author":"J Wang","year":"2016","unstructured":"Wang J, Liu Y, Yang Y, Xu Z, Zhang G, Liu Z, et al. High expression of galectin-7 associates with poor overall survival in patients with non-metastatic clear-cell renal cell carcinoma. Oncotarget. 2016;7:41986\u201395.","journal-title":"Oncotarget."},{"key":"1108_CR29","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.3892\/ol.2017.5649","volume":"13","author":"JP Guo","year":"2017","unstructured":"Guo JP, Li XG. Galectin-7 promotes the invasiveness of human oral squamous cell carcinoma cells via activation of ERK and JNK signaling. Oncol Lett. 2017;13:1919\u201324.","journal-title":"Oncol Lett"},{"key":"1108_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms18061230","volume":"18","author":"H Schulz","year":"2017","unstructured":"Schulz H, Schmoeckel E, Kuhn C, Hofmann S, Mayr D, Mahner S, et al. Galectins-1, -3, and -7 are prognostic markers for survival of ovarian cancer patients. Int J Mol Sci. 2017;18:1\u201312.","journal-title":"Int J Mol Sci."},{"key":"1108_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12040953","volume":"12","author":"A Trebo","year":"2020","unstructured":"Trebo A, Ditsch N, Kuhn C, Heidegger HH, Zeder-Goess C, Kolben T, et al. High galectin-7 and low galectin-8 expression and the combination of both are negative prognosticators for breast cancer patients. Cancers. 2020;12:1\u201321.","journal-title":"Cancers"},{"key":"1108_CR32","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1245\/ASO.2006.08.033","volume":"13","author":"S Saussez","year":"2006","unstructured":"Saussez S, Cucu DR, Decaestecker C, Chevalier D, Kaltner H, Andr\u00e9 S, et al. Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer. Ann Surg Oncol. 2006;13:999\u20131009.","journal-title":"Ann Surg Oncol"},{"key":"1108_CR33","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1038\/sj.onc.1206631","volume":"22","author":"J Kopitz","year":"2003","unstructured":"Kopitz J, Andre S, von Reitzenstein C, Versluis K, Kaltner H, Pieters RJ, et al. Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells. Oncogene. 2003;22:6277\u201388.","journal-title":"Oncogene."},{"key":"1108_CR34","doi-asserted-by":"publisher","first-page":"5672","DOI":"10.1158\/0008-5472.CAN-04-0985","volume":"64","author":"S Ueda","year":"2004","unstructured":"Ueda S, Kuwabara I, Liu FT. Suppression of tumor growth by galectin-7 gene transfer. Cancer Res. 2004;64:5672\u20136.","journal-title":"Cancer Res"},{"key":"1108_CR35","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.18632\/oncotarget.1219","volume":"4","author":"SJ Kim","year":"2013","unstructured":"Kim SJ, Hwang JA, Ro JY, Lee YS, Chun KH. Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer. Oncotarget. 2013;4:1461\u201371.","journal-title":"Oncotarget."},{"key":"1108_CR36","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1002\/ijc.27764","volume":"132","author":"H Zhu","year":"2013","unstructured":"Zhu H, Wu TC, Chen WQ, Zhou LJ, Wu Y, Zeng L, et al. Roles of galectin-7 and S100A9 in cervical squamous carcinoma: clinicopathological and in vitro evidence. Int J Cancer. 2013;132:1051\u20139.","journal-title":"Int J Cancer"},{"key":"1108_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2700-8","volume":"16","author":"JC Higareda-Almaraz","year":"2016","unstructured":"Higareda-Almaraz JC, Ruiz-Moreno JS, Klimentova J, Barbieri D, Salvador-Gallego R, Ly R, et al. Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment. BMC Cancer. 2016;16:680.","journal-title":"BMC Cancer"},{"key":"1108_CR38","first-page":"41","volume":"24","author":"Z Cada","year":"2009","unstructured":"Cada Z, Chovanec M, Smetana K Jr, Betka J, Lacina L, Plz\u00e1k J, et al. Galectin-7: will the lectin\u2019s activity establish clinical correlations in head and neck squamous cell and basal cell carcinomas? Histol Histopathol. 2009;24:41\u201348.","journal-title":"Histol Histopathol."},{"key":"1108_CR39","doi-asserted-by":"publisher","unstructured":"Condamine T, Kumar V, Ramachandran I, Youn J, Celis E, Finnberg N, et al. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. J Clin Invest. 2014;124. https:\/\/doi.org\/10.1172\/JCI74056.","DOI":"10.1172\/JCI74056."},{"key":"1108_CR40","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1093\/bioinformatics\/btp450","volume":"25","author":"M Morgan","year":"2009","unstructured":"Morgan M, Anders S, Lawrence M, Aboyoun P, Pages H, Gentleman R. Short Read, a bioconductor package for input, quality assessment and exploration of high-throughput sequence data. Bioinformatics. 2009;25:2607\u20138.","journal-title":"Bioinformatics."},{"key":"1108_CR41","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkt214","volume":"41","author":"Y Liao","year":"2013","unstructured":"Liao Y, Smyth GK, Shi W. The Subread aligner, fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 2013;41:e108.","journal-title":"Nucleic Acids Res"},{"key":"1108_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"1108_CR43","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr, a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:90\u201397.","journal-title":"Nucleic Acids Res"},{"key":"1108_CR44","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ni.1772","volume":"10","author":"JM Ilarregui","year":"2009","unstructured":"Ilarregui JM, Croci DO, Bianco GA, Toscano MA, Salatino M, Vermeulen ME, et al. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat Immunol. 2009;10:981\u201391.","journal-title":"Nat Immunol."},{"key":"1108_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ccell.2014.11.009","volume":"27","author":"MR Rutkowski","year":"2015","unstructured":"Rutkowski MR, Stephen TL, Svoronos N, Allegrezza MJ, Tesone AJ, Perales-Puchalt A, et al. Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation. Cancer Cell. 2015;27:27\u201340.","journal-title":"Cancer Cell"},{"key":"1108_CR46","doi-asserted-by":"publisher","first-page":"e3631","DOI":"10.7717\/peerj.3631","volume":"5","author":"VLT Hoang","year":"2017","unstructured":"Hoang VLT, Tom LN, Quek XC, Tan JM, Payne EJ, Lin LL, et al. RNA-seq reveals more consistent reference genes for gene expression studies in human non-melanoma skin cancers. Peer J. 2017;5:e3631.","journal-title":"Peer J."},{"key":"1108_CR47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.coi.2016.12.003","volume":"45","author":"SP Mendez-Huergo","year":"2017","unstructured":"Mendez-Huergo SP, Blidner AG, Rabinovich GA. Galectins, emerging regulatory checkpoints linking tumor immunity and angiogenesis. Curr Opin Immunol. 2017;45:8\u201315.","journal-title":"Curr Opin Immunol."},{"key":"1108_CR48","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cell.2012.04.042","volume":"150","author":"S Acharyya","year":"2012","unstructured":"Acharyya S, Oskarsson T, Vanharanta S, Malladi S, Kim J, Morris PG, et al. A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell. 2012;150:165\u201378.","journal-title":"Cell."},{"key":"1108_CR49","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.canlet.2021.08.015","volume":"521","author":"MS Park","year":"2021","unstructured":"Park MS, Yang AY, Lee JE, Kim SK, Roe JS, Park MS, et al. GALNT3 suppresses lung cancer by inhibiting myeloid-derived suppressor cell infiltration and angiogenesis in a TNFR and c-MET pathway-dependent manner. Cancer Lett. 2021;521:294\u2013307.","journal-title":"Cancer Lett"},{"key":"1108_CR50","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.1158\/0008-5472.CAN-15-3541","volume":"76","author":"F Xing","year":"2016","unstructured":"Xing F, Liu Y, Sharma S, Wu K, Chan MD, Lo HW, et al. Activation of the c-met pathway mobilizes an inflammatory network in the brain microenvironment to promote brain metastasis of breast cancer. Cancer Res. 2016;76:4970\u201380.","journal-title":"Cancer Res"},{"key":"1108_CR51","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41568-018-0002-y","volume":"18","author":"PM Comoglio","year":"2018","unstructured":"Comoglio PM, Trusolino L, Boccaccio C. Known and novel roles of the MET oncogene in cancer, a coherent approach to targeted therapy. Nat Rev Cancer. 2018;18:341\u201358.","journal-title":"Nat Rev Cancer."},{"key":"1108_CR52","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1158\/2159-8290.CD-19-1446","volume":"10","author":"G Recondo","year":"2020","unstructured":"Recondo G, Che J, J\u00e4nne PA, Awad MM. Targeting MET dysregulation in cancer. Cancer Discov. 2020;10:922\u201334.","journal-title":"Cancer Discov."},{"key":"1108_CR53","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1126\/science.1237910","volume":"342","author":"M Shan","year":"2013","unstructured":"Shan M, Gentile M, Yeiser JR, Walland AC, Bornstein VU, Chen K, et al. Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science. 2013;342:447\u201353.","journal-title":"Science."},{"key":"1108_CR54","doi-asserted-by":"publisher","first-page":"22662","DOI":"10.1074\/jbc.M115.644799","volume":"290","author":"S Thiemann","year":"2015","unstructured":"Thiemann S, Man JH, Chang MH, Lee B, Baum LG. Galectin-1 regulates tissue exit of specific dendritic cell populations. J Biol Chem. 2015;290:22662\u201377.","journal-title":"J Biol Chem"},{"key":"1108_CR55","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.immuni.2012.05.023","volume":"37","author":"SC Starossom","year":"2021","unstructured":"Starossom SC, Mascanfroni ID, Imitola J, Cao L, Raddassi K, Hernandez SF, et al. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity. 2021;37:249\u201363.","journal-title":"Immunity."},{"key":"1108_CR56","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.4049\/jimmunol.0903275","volume":"185","author":"V Dardalhon","year":"2010","unstructured":"Dardalhon V, Anderson AC, Karman J, Apetoh L, Chandwaskar R, Lee DH, et al. Tim-3\/galectin-9 pathway, regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells. J Immunol. 2010;185:1383\u201392.","journal-title":"J Immunol."},{"key":"1108_CR57","doi-asserted-by":"publisher","first-page":"e1163461","DOI":"10.1080\/2162402X.2016.1163461","volume":"5","author":"GJ Baker","year":"2016","unstructured":"Baker GJ, Chockley P, Zamler D, Castro MG, Lowenstein PR. Natural killer cells require monocytic Gr-1(+)\/CD11b(+) myeloid cells to eradicate orthotopically engrafted glioma cells. Oncoimmunology. 2016;5:e1163461\u20131-13.","journal-title":"Oncoimmunology."},{"key":"1108_CR58","doi-asserted-by":"publisher","first-page":"E3769","DOI":"10.1073\/pnas.1722434115","volume":"115","author":"CA Orozco","year":"2018","unstructured":"Orozco CA, Martinez-Bosch N, Guerrero PE, Vinaixa J, Dalotto-Moreno T, Iglesias M, et al. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk. Proc Natl Acad Sci USA. 2018;115:E3769\u2013E3778.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1108_CR59","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1038\/jid.2009.96","volume":"129","author":"MJ Bluth","year":"2009","unstructured":"Bluth MJ, Zaba LC, Moussai D, Su\u00e1rez-Fari\u00f1as M, Kaporis H, Fan L, et al. Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation. J Invest Dermatol. 2009;129:2451\u201362.","journal-title":"J Invest Dermatol"},{"key":"1108_CR60","doi-asserted-by":"publisher","unstructured":"An J, Nagaki Y, Motoyama S, Kuze Y, Hoshizaki M, Kemuriyama K et al. Identification of Galectin-7 as a crucial metastatic enhancer of squamous cell carcinoma associated with immunosuppression. Oncogene. 2022; https:\/\/doi.org\/10.1038\/s41388-022-02525-1.","DOI":"10.1038\/s41388-022-02525-1."},{"key":"1108_CR61","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ccell.2019.06.006","volume":"36","author":"S Mereiter","year":"2019","unstructured":"Mereiter S, Balma\u00f1a M, Campos D, Gomes J, Reis CA. Glycosylation in the era of cancer-targeted therapy, where are we heading? Cancer Cell. 2019;36:6\u201316.","journal-title":"Cancer Cell"},{"key":"1108_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2018.00070","volume":"8","author":"U M\u00f6ginger","year":"2018","unstructured":"M\u00f6ginger U, Grunewald S, Hennig R, Kuo CW, Schirmeister F, Voth H, et al. Alterations of the human skin N- and O-glycome in basal cell carcinoma and squamous cell carcinoma. Front Oncol. 2018;8:1\u201318.","journal-title":"Front Oncol."},{"key":"1108_CR63","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1023\/B:GLYC.0000014075.62724.d0","volume":"19","author":"CF Brewer","year":"2002","unstructured":"Brewer CF. Thermodynamic binding studies of galectin-1, -3 and -7. Glycoconj J. 2002;19:459\u201365.","journal-title":"Glycoconj J."},{"key":"1108_CR64","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/exd.12268","volume":"22","author":"T Yamaguchi","year":"2013","unstructured":"Yamaguchi T, Hiromasa K, Kabashima-Kubo R, Yoshioka M, Nakamura M. Galectin-7, induced by cis-urocanic acid and ultraviolet B irradiation, down-modulates cytokine production by T lymphocytes. Exp Dermatol. 2013;22:840\u20132.","journal-title":"Exp Dermatol."},{"key":"1108_CR65","doi-asserted-by":"publisher","first-page":"e72468","DOI":"10.1371\/journal.pone.0072468","volume":"8","author":"CG Campion","year":"2013","unstructured":"Campion CG, Labrie M, Lavoie G, St-Pierre Y. Expression of galectin-7 is induced in breast cancer cells by mutant p53. PLoS One. 2013;8:e72468.","journal-title":"PLoS One"},{"key":"1108_CR66","doi-asserted-by":"publisher","first-page":"e0119031","DOI":"10.1371\/journal.pone.0119031","volume":"10","author":"G Gendronneau","year":"2015","unstructured":"Gendronneau G, Sanii S, Dang T, Deshayes F, Delacour D, Pichard E, et al. Overexpression of galectin-7 in mouse epidermis leads to loss of cell junctions and defective skin repair. PLoS One. 2015;10:e0119031.","journal-title":"PLoS One"},{"key":"1108_CR67","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","volume":"19","author":"F Veglia","year":"2018","unstructured":"Veglia F, Perego M, Gabrilovich D. Myeloid-derived suppressor cells coming of age. Nat Immunol. 2018;19:108\u201319.","journal-title":"Nat Immunol"},{"key":"1108_CR68","first-page":"1","volume":"1","author":"F Veglia","year":"2021","unstructured":"Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat. Rev. Immunol. 2021;1:1\u201314.","journal-title":"Nat. Rev. Immunol."},{"key":"1108_CR69","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1084\/jem.20140835","volume":"212","author":"ML Ortiz","year":"2015","unstructured":"Ortiz ML, Kumar V, Martner A, Mony S, Donthireddy L, Condamine T, et al. Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells. J Exp Med. 2015;212:351\u201367.","journal-title":"J Exp Med"},{"key":"1108_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scisignal.aaf5106","volume":"9","author":"C Cataisson","year":"2016","unstructured":"Cataisson C, Michalowski AM, Shibuya K, Ryscavage A, Klosterman M, Wright L, et al. MET signaling in keratinocytes activates EGFR and initiates squamous carcinogenesis. Sci Signal. 2016;9:1\u201316.","journal-title":"Sci Signal."},{"key":"1108_CR71","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1053\/j.gastro.2008.01.014","volume":"134","author":"Y Inagaki","year":"2008","unstructured":"Inagaki Y, Higashi K, Kushida M, Hong YY, Nakao S, Higashiyama R, et al. Hepatocyte growth factor suppresses profibrogenic signal transduction via nuclear export of Smad3 with galectin-7. Gastroenterology. 2008;134:1180\u201390.","journal-title":"Gastroenterology."},{"key":"1108_CR72","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3390\/biom11060879","volume":"11","author":"Y St-Pierre","year":"2021","unstructured":"St-Pierre Y. Towards a better understanding of the relationships between Galectin-7, p53 and MMP-9 during cancer progression. Biomolecules. 2021;11:879.","journal-title":"Biomolecules."},{"key":"1108_CR73","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1742-4658.2011.08414.x","volume":"279","author":"G Masuyer","year":"2012","unstructured":"Masuyer G, Jabeen T, \u00d6berg CT, Leffler H, Nilsson UJ, Acharya KR. Inhibition mechanism of human galectin-7 by a novel galactose-benzylphosphate inhibitor. FEBS J. 2012;279:193\u2013202.","journal-title":"FEBS J"},{"key":"1108_CR74","doi-asserted-by":"publisher","first-page":"40970","DOI":"10.18632\/oncotarget.5403","volume":"6","author":"MC Vladoiu","year":"2015","unstructured":"Vladoiu MC, Labrie M, L\u00e9tourneau M, Egesborg P, Gagn\u00e9 D, Billard \u00c9, et al. Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin. Oncotarget. 2015;6:40970\u201380.","journal-title":"Oncotarget."},{"key":"1108_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10456-020-09749-3","volume":"24","author":"J P\u00e9rez S\u00e1ez","year":"2020","unstructured":"P\u00e9rez S\u00e1ez J, Hockl P, Cagnoni A, M\u00e9ndez Huergo S, Garc\u00eda P, Gatto S, et al. Characterization of a neutralizing anti-human galectin-1 monoclonal antibody with angioregulatory and immunomodulatory activities. Angiogenesis. 2020;24:1\u20135.","journal-title":"Angiogenesis."}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-022-01108-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-022-01108-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-022-01108-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T07:04:28Z","timestamp":1680505468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-022-01108-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1108"],"URL":"https:\/\/doi.org\/10.1038\/s41418-022-01108-7","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,24]]},"assertion":[{"value":"20 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}